REINREUDE PROVIDES TEMPORARY RELIEF FOR MINOR MUSCLE AND JOINT PAIN- lidocaine 4% provides temporary relief for minor muscle and joint pain patch

REINREUDE PROVIDES TEMPORARY RELIEF FOR MINOR MUSCLE AND JOINT PAIN by

Drug Labeling and Warnings

REINREUDE PROVIDES TEMPORARY RELIEF FOR MINOR MUSCLE AND JOINT PAIN by is a Otc medication manufactured, distributed, or labeled by Jiangxi Hemei Pharmaceutical Co., Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredient

Lidocaine 4%

Purpose

Pain Relief

Use

▆temporarily relieves minor pain associated with:

▆arthritis ▆simple backache▆bursitis ▆tendonitis ▆muscle strains ▆sprains▆bruises ▆cramps

Warnings

For external use only

Do not use

▆avoid contact with eyes and mucous membranes

▆ do not apply to wounds or damaged skin, broken or irritated skin

▆do not bandage tightly or apply local heat (such as heating pads) to the area of use

When Using

▆use only as directed. Read and follow all directions and warnings on this carton.

▆avoid contact with eyes and mucous membranes

▆rare cases of serious burns have been reported with products of this type

▆ do not apply to wounds or damaged skin, broken or irritated skin

▆do not bandage tightly or apply local heat (such as heating pads) to the area of use

▆ A transient burning sensation may occur upon application but usually disappears within a few days.

Stop Use

▆condition worsens

▆redness is present

▆irritation develops

▆symptoms persist for more than 7 days or clear up and occur again within a few dsys

▆you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

If pregnant or breast-feeding. ask a health professional before use

Ask Doctor

▆condition worsens ▆redness is present ▆irritation develops▆symptoms persist for more than 7 days or clear up and occur again within a few dsys ▆you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

Keep Oot Of Reach Of Children

lf swallowed, get medical help or contact a Poison Control Center right away

Directions

adults and children over 12 years.

▆remove backing from patch by firmly grasping both ends and gently pulling until backing separate in middle ▆carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area ▆once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected area ▆Wear one patch for up to 8 hours.

▆Repeat if needed, but do not use more than 3 times daily.

children 12 years or younger: ask a doctor

Inactive ingredients

water, aluminym hvdroxide, cellulose gum, glvcerin, isopropyl myristate, nonoxynol-30, polyacrylic aciopolysorbate 80, sodium polvacrvlate, sorbitan sesauioleate,Starch, talc, tartaric acid,titanium dioxide

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

REINREUDE PROVIDES TEMPORARY RELIEF FOR MINOR MUSCLE AND JOINT PAIN 
lidocaine 4% provides temporary relief for minor muscle and joint pain patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84010-099
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	4 g  in 100

Inactive Ingredients
Ingredient Name	Strength
CELLULOSE GUM (UNII: K679OBS311)
WATER (UNII: 059QF0KO0R)
POLYACRYLIC ACID (250000 MW) (UNII: 9G2MAD7J6W)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
TALC (UNII: 7SEV7J4R1U)
TARTARIC ACID (UNII: W4888I119H)
SORBITAN SESQUIOLEATE (UNII: 0W8RRI5W5A)
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)
POLYSORBATE 80 (UNII: 6OZP39ZG8H)
NONOXYNOL-30 (UNII: JJX07DG188)
STARCH, CORN (UNII: O8232NY3SJ)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84010-099-01	8 in 1 BOX; Type 0: Not a Combination Product	04/15/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M017	04/15/2025

Labeler - Jiangxi Hemei Pharmaceutical Co., Ltd (724892056)

Establishment
Name	Address	ID/FEI	Business Operations
Jiangxi Hemei Pharmaceutical Co., Ltd		724892056	manufacture(84010-099)